[Global Kinetics in Financial Review] OurCrowd reaches $1bn funds under management with $200m from Australian backers

OurCrowd’s lone Australian investment, Global Kinetics Corporation – a provider of a smartwatch which tracks Parkinson’s disease symptoms – is part of this fund.

Read more on Financial Review here.